Steward Partners Investment Advisory’s Unity Biotechnology UBX Stock Holding History

Steward Partners Investment Advisory’s Portfolio UBX Stock Details UBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,000	Closed	-$56	–	4468
2025 Q3	$56	Sell	1,000 -1	-0.1%	–	﹤0.01%	4209
2025 Q2	$384	Buy	1,001 +1	+0.1%	+$1	﹤0.01%	3985
2025 Q1	$1.04K	Hold	1,000	–	–	﹤0.01%	3765
2024 Q4	$976	Sell	1,000 -1,000	-50%	-$1.24K	﹤0.01%	3757
2024 Q3	$2.94K	Sell	2,000 -1,500	-43%	-$2.2K	﹤0.01%	3356
2024 Q2	$4.72K	Sell	3,500 -2,843	-45%	-$4.32K	﹤0.01%	3062
2024 Q1	$10.4K	Buy	+6,343	New	+$11K	﹤0.01%	2797

Steward Partners Investment Advisory's UBX Position: Q4 2025 in Review

Steward Partners Investment Advisory sold out of Unity Biotechnology (UBX) in Q4 2025, closing a stake of 1,000 shares — an estimated $56 sold.

Steward Partners Investment Advisory first reported a position in UBX in Q1 2024 and held it in 7 quarters. The position peaked at $10.4K in Q1 2024. 0 funds tracked by Wall St. Rank hold UBX as of Q4 2025.

Steward Partners Investment Advisory reported no remaining Unity Biotechnology position as of Q4 2025 after selling out during the quarter.
Steward Partners Investment Advisory sold 1,000 Unity Biotechnology shares in Q4 2025, an estimated $56.
Steward Partners Investment Advisory first reported a position in Unity Biotechnology in Q1 2024 and held it in 7 quarters.
Steward Partners Investment Advisory's Unity Biotechnology position peaked at $10.4K in Q1 2024.
0 funds tracked by Wall St. Rank held Unity Biotechnology as of Q4 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2025, filed 12 Feb 2026.